Ken Griffin Integra Lifesciences Holdings Corp Put Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$17.14 - $31.74 $102,840 - $190,440	6,000 Added 142.86%	10,200 $185,000
Q2 2024 Aug 14, 2024	BUY	$23.14 - $34.72 $37,024 - $55,552	1,600 Added 61.54%	4,200 $122,000
Q1 2024 May 15, 2024	BUY	$33.4 - $45.2 $86,840 - $117,520	2,600 New	2,600 $92,000
Q1 2023 May 15, 2023	SELL	$52.61 - $60.49 $1.1 Million - $1.26 Million	-20,900 Reduced 90.48%	2,200 $126,000
Q4 2022 Feb 14, 2023	BUY	$42.17 - $58.6 $708,456 - $984,480	16,800 Added 266.67%	23,100 $1.3 Million
Q3 2022 Nov 14, 2022	BUY	$42.28 - $57.17 $266,364 - $360,171	6,300 New	6,300 $267,000

240

74.9M

585K

21.3K

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.9B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.